Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like they have PRd the new kiosk: Electronic Cigarettes International Group Launches VIP Kiosk In South Africa
http://www.marketwatch.com/story/electronic-cigarettes-international-group-launches-vip-kiosk-in-south-africa-2016-08-17?siteid=nbsh
lol! Thanks for the smile MIKAL :)
Thanks shady, i believe the new commercial is by this same group.
Is anyone else seeing the anti-vaping commercial, the song they play is One Way or Another (we're gonna get ya) and the spin is that big t is really behind ecigs in order to get teens started vaping and then go on to smoking. I can't find a video online on it yet, it seems new? Maybe it is only running in CA.
"The newest flavors will be made available on VitaminFIZZ social media in the coming days."
It sounds like this is referring to new flavors of regular formulation FIZZ becoming available soon?
Costco Is Quietly Removing Tobacco From Most of its Stores
http://www.thestreet.com/story/13494053/1/costco-is-quietly-removing-tobacco-from-most-of-its-stores.html?puc=_htmlatb_pla2&cm_ven=EMAIL_htmlatb
This may also bring new interest to ECIG:
Vapor Corp announces Reverse Stock Split
http://ir.vapor-corp.com/press-releases/detail/582
$ECIG$
Either way, something has to give at some point, e.g. the cell or rebranding, because with no cell our name basically makes no sense. As always, looking forward to knowing more as this unfolds, and hopefully soon. And as you said, GLTA! (been away a while but try to keep up when i can) ;)
PERSEON new filings as of 1/11/2016:
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. Compensatory Arrangements of Certain Officers (CEO)
http://investor.perseonmedical.com/phoenix.zhtml?c=75162&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTEwNjY3MzcwJkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3
13,225,000 shares of Common Stock issuable upon the exercise of the 13,225,000 outstanding Warrants issued
in our public offering
http://investor.perseonmedical.com/phoenix.zhtml?c=75162&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTEwNjY3Mzg0JkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3
Extension of the offer expiration date from Perseon Form SC TO/T-A:
"All references to “11:59 PM, New York City Time, on December 7, 2015” as the “Expiration Date” are hereby amended to refer to “11:59 PM, New York City Time, on December 21, 2015”."
From Galil PR:
Galil Medical Extends Tender Offer Period to Acquire Perseon Corporation
Arden Hills, MN, and Salt Lake City, UT– December 2, 2015 – Galil Medical Ltd. ('Galil"), a global leader in delivering innovative cryotherapy ablation solutions, today announced Galil's indirect wholly owned subsidiary Galil Merger Sub, Inc. has extended its previously announced tender offer to purchase (i) all of the outstanding publicly traded shares of Perseon Corporation (NASDAQ: PRSN; PRSNW) common stock for $1.00 per share in cash, and (ii) all of the outstanding publicly traded warrants to purchase Perseon common stock for $0.02 per warrant (the "Offer"). The Offer will now expire immediately after 11:59 p.m., Eastern Time, on December 21, 2015, unless it is further extended. All other terms and conditions of the Offer remain unchanged.
Staters update - I just called one of the 4 nearby stores and the manager said that FIZZ is in fact showing up on their ppwk and he went ahead and ordered a case of each for me, he said if it's in the warehouse (San Bernardino) it'll be in his store Wed morning (11/4). He'll call me if/when it arrives. He is showing 4 flavors available - MO BR SL SW (still no LL for me!)
The SIX PILLARS from the 8/10 cc transcript:
"I’d like to turn our attention to the strategic drivers that I mentioned earlier and how we will operate and valuate our business going forward. The mission to deliver profitable growth to enhance shareholder value, it’s important aspect of everything we’re going to do. So I’ll repeat it, deliver profitable growth or drive profitable growth to enhance shareholder value.
The six supporting strategic drivers. Number one; establish VIP as an international premium brand; number two, utilize FIN and Vapestick as for additional retail brands; number three, expand profitably into non-traditional challenge. You will see that these first three strategic drivers are focused on the distribution network and how we will go to market. Its' an incredibly important distinction where most companies would look at each country, we are looking them at by channel. And that's a key distinction and it's a big opportunity we feel in this market.
The last three pillars; number four, strengthen the organizational talent pool; number five, become a low cost provider of the product; and number six, improve our working capital."
Link to cc transcript: http://seekingalpha.com/article/3425526-electronic-cigarettes-internationals-ecig-ceo-dan-oneill-on-q2-2015-results-earnings-call-transcript?page=2
$ECIG
"..in response to continued strong customer demand across the United States.
Regarded as the most convenient, user-friendly vaping solution in the market, the FIN AVS line has increased distribution in 2,500 new outlets moving the total number of new points of distribution to 8,500 since early October."
There is also emphasis in this PR that the FIN AVS is a popular product.
It's nice to have this consistent, steady stream of communication now that Dan is here. And I like how he keeps referencing his strategy and pillars. GLTUA!
From the 8-K:
Item 1.01 Entry Into a Material Definitive Agreement.
On October 26, 2015, Perseon Corporation, a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Galil Medical, Inc., a Delaware corporation (“Galil”), and Galil Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Galil (“Merger Sub”), pursuant to which Merger Sub will, on the terms and subject to the conditions set forth therein, conduct a tender offer for (i) all of the Company’s outstanding common stock (the “Common Stock”) and (ii) all of the Company's outstanding warrants to purchase common stock traded on The Nasdaq Capital Market (the “Public Warrants” and, together with the Common Stock, the “Securities”) and then merge with and into the Company.
Pursuant to the Merger Agreement, upon the terms and subject to the conditions set forth therein, Merger Sub will commence a tender offer (the “Offer”) no later than November 5, 2015 to acquire (i) all outstanding shares of Common Stock at a purchase price of $1.00 per share (the “Shares Offer Price”) and (ii) all outstanding Public Warrants at a purchase price of $0.02 per Public Warrant (the “Public Warrants Offer Price”), with each payment in cash without interest, subject to any deduction or withholding of taxes required by applicable law. The Merger Agreement further provides that upon the terms and subject to the conditions set forth therein, following completion of the Offer, Merger Sub will merge with and into the Company, with the Company continuing as the surviving corporation and as a wholly owned subsidiary of Galil (the “Merger”). The Merger will be governed by Section 251(h) of the General Corporation Law of the State of Delaware (the “DGCL”), with no vote of the Company’s stockholders required to consummate the Merger. In the Merger, each (i) outstanding share of Common Stock (other than shares of Common Stock held by the Company, Galil, Merger Sub or any of their respective subsidiaries or held by stockholders who are entitled to demand, and who properly demand, appraisal rights under Delaware law) and (ii) Public Warrant (other than Public Warrants held by the Company, Galil, Merger Sub or any of their respective subsidiaries) will be converted into the right to receive cash in an amount equal to the Shares Offer Price and Public Warrants Offer Price, respectively, without interest.
http://investor.perseonmedical.com/phoenix.zhtml?c=75162&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTEwNTQwMDQ1JkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3
Congrats, derek! and to all longs!!
Galil Medical Enters Into Agreement to Acquire Perseon Corporation to Create Leader in Ablation Treatment for Tumors
http://investor.perseonmedical.com/phoenix.zhtml?c=75162&p=irol-newsArticle&ID=2102622
San Bernardino County. I have been watching my local Stater's, too, and when the FIZZ arrives, I'll be buying! (if colored caps, which I'm sure they must be at this point). I have five Stater's near me, so I'll get some pix for the board. :)
Well, the bottles at Vallarta have lost theirs. I bought a case of PC and some loose bottles of BR two days ago and they are flat. Not 100% flat, but definitely not how they were when they first arrived there. And this does effect the overall taste, imo. These have the clear caps. I won't buy any more of the clear caps, to be on the safe side. Just reporting as it is because having eyes and ears everywhere helps all of us.
Happy Birthday, Stok! Thank you for your posts. Peace :)))
Nice! Lots of "small" victories beginning to stack up.
GO Dan GO Ecig
PRSN and my two other OTCs GREEN on a Red Sea market day. Sometimes OTC is a nice place to be. ;))
That makes sense, sickpuppy. It would help explain the twist and turn, bob and weave moves that happened that many of us weren't expecting. (I said many of us, not all lol)
StoryTRADING highlighting PRSN:
http://www.storytrading.com/prsn-the-next-aqxp-find-out-the-11-reasons-to-own-it/
Thanks, D!
"...the Company has until March 14, 2016 to demonstrate compliance by maintaining a minimum closing bid price of at least $1.00 for a minimum of ten consecutive business days."
PERSEON website updated with new INSPIRE 2017 pop-up to register for spreading the word about the technology.
http://perseonmedical.com/inspire2017.html
And there will be a new CFO, too.
"Perseon has initiated a CFO search and Mr. Barth will stay on board until December 31, 2015, or when a successor is identified and appointed."
http://investor.perseonmedical.com/phoenix.zhtml?c=75162&p=irol-newsArticle&ID=2084075
Hi Leering, Fizz has not yet appeared in the Stater Bros stores that I have checked (3). I emailed Minerco asking about it and received the reply that my email was forwarded to the marketing department for action.
Sticking around to see what happens here.
btw love the FizzLand lol
Nice!! Thanks moe!
WATCH Perseon's 9/10/2015 Presentation here:
http://wsw.com/webcast/rrshq25/prsn/index.aspx
(You have to manually advance the 32 slides)
LINK to webcast 9/10/2015 11:40 AM (ET)
http://wsw.com/webcast/rrshq25/register.aspx?conf=rrshq25&page=prsn&url=http://wsw.com/webcast/rrshq25/prsn/index.aspx
WHERE is the Like button?? lol
Thanks for your posts and DD! There should be more information coming our way because of the INSPIRE campaign, which they called a "dramatic effort" to raise awareness of this disruptive technology. And so far management has been very good with communication. We'll see what they say tomorrow!
Hi mighty, I just read the Bloomberg link and their description, there's been an update since then, not sure if you knew, Carnell wants Perseon to focus only on the MicroThermX system now.
“Since joining BSD in November, I have made some initial observations based on extensive meetings with customers, employees, and physicians that have informed our strategic plan for the next several years,” said Clint Carnell, CEO of BSD Medical. “What’s clear to me is that BSD is an established leader in groundbreaking medical systems to treat cancer with heat therapy, and the MicroThermX® system is the leading microwave ablation technology. However, the Company’s dual focus on hyperthermia and microwave ablation since 2010 has diluted our ability to effectively market, sell, and invest in the commercial success of both businesses. Success in Life Sciences requires an evidence-based approach coupled with top line sales growth through customer adoption – and in order for BSD to be successful, we need to focus on microwave ablation. In 2015, we intend to focus on successfully exiting our hyperthermia business, and implementing a strategic plan that is exclusively focused on our highest return opportunity – the disruptive, high-growth microwave ablation market."
Link to PR that has the above: http://investor.perseonmedical.com/phoenix.zhtml?c=75162&p=irol-newsArticle&ID=2057294
I need to look at the last CC transcripts (cc from 8/7), but i think i remember him saying during the call that they are now totally free of the hyperthermia business, and it's all about MicroThermX now.
I look forward to it, too. Carnell is doing the presentation, should be some good info! This company seems to be flying under everyone's radar, glad they'll be there and drawing some attention.
Nice!! I added the link to the Intro. :)
LINK to Rodman & Renshaw live webcast 9/10/2015 11:40 AM (ET)
http://wsw.com/webcast/rrshq25/register.aspx?conf=rrshq25&page=prsn&url=http://wsw.com/webcast/rrshq25/prsn/index.aspx
Perseon to Present at Rodman & Renshaw 17th Annual Global Investment Conference
http://investor.perseonmedical.com/phoenix.zhtml?c=75162&p=irol-newsArticle&ID=2086010
Nice post, mighty! Stickied :)
NEWS - Perseon Announces the Initiation of the First Multi-Organ in vivo Ablation Zone Study for MicroThermX(R) in Laparoscopic and Open Approaches
http://investor.perseonmedical.com/phoenix.zhtml?c=75162&p=irol-newsArticle&ID=2083224
"This trial is pivotal for Perseon, as it marks the first in vivo trial of its kind for MicroThermX," said Brian A. Meltzer, Chief Medical Officer of Perseon. "The push for real world results reinforces our commitment to clinically relevant data and further shows how our Synchronous Wave Alignment Technology provides added efficiency for physicians in the field of energy ablation."